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Neutrophilic dermatoses comprise a heterogeneous group of disorders, which are characterized by in-
ﬂammatory skin lesions that share a common histopathological feature, intense inﬂammatory inﬁltration
consisting primarily of neutrophils, with no evidence of vasculitis. We describe a 75-year-old man with
rheumatoid arthritis, who presented with erythematous edematous plaques. The histopathological
ﬁndings indicated neutrophilic dermatosis; however, the patient was afebrile and without an elevated
white blood cell count or systemic involvement. We think that the most suitable expression for this
variant with clinical manifestations different from those of classical Sweet syndrome is “chronic recur-
rent annular neutrophilic dermatosis,” as introduced by Christensen et al.1
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The term “chronic recurrent annular neutrophilic dermatosis
(CRAND)” was ﬁrst used by Christensen et al1 in 1989 to refer to the
skin lesions of two patients who had chronically recurring out-
breaks of generalized annular erythematous, edematous cutaneous
plaques with histopathological ﬁndings suggestive of Sweet syn-
drome, but without fever or systemic signs and symptoms.Case Report
We describe a 75-year-old man with a 10-year history of rheuma-
toid arthritis (RA) who presented to our clinic with recurrent out-
breaks of edematous, inﬁltrated, annular, erythematous plaques
with a violaceous center. The lesions ﬁrst appeared ~3 years before
admission, were located on the patient’s trunk, arms, legs, neck,ave no ﬁnancial or
ct matter or materials
esearch Hospital, Darulaceze
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al Association. Published by Elseviand scalp (Figures 1Ae1C), and lasted for 3 weeks. The family
history was negative for similar conditions. Upon admission, the
patient was afebrile, and did not have malaise, myalgia, or
lymphadenopathy. He had been taking nonsteroidal anti-
inﬂammatory drugs for RA for 10 years. A complete blood count
revealed anemia of chronic disease, and the results of routine
biochemical testing were normal. His C-reactive protein level was
81 mg/L (reference range, 0e5 mg/L) and erythrocyte sedimenta-
tion rate was 71 mm/h (reference range, <20 mm/h). Chest radi-
ography revealed sequelae of tuberculosis in both pulmonary
apices. Abdominal ultrasound showed a solid intravesical bladder
mass. The histopathological ﬁndings of a biopsy of the mass were
consistent with papillomatous hyperplasia. Serological testing for
evidence of infection with hepatotropic viruses, human immuno-
deﬁciency virus, and syphilis was negative. No other serological
testing was performed. The patient was negative for the tumor
markers prostate-speciﬁc antigen, carcinoembryonic antigen, and
cancer antigen-19.9, and his stool was negative for occult blood.
Serum immunoelectropheresis ﬁndings were also normal. Together
with the patient’s physical examination and history, the clinical
assessment was negative for an underlying malignancy, and no
additional investigations for the presence of an underlying malig-
nant tumor were performed.er Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Figure 1 (A) Erythematous, edematous, annular plaques with violaceous center
located on the trunk; (B) annular erythematous, edematous lesions located on the
upper trunk and neck; (C) reddish-violaceous annular lesions on the arms.
Figure 2 (A) Edema and intense neutrophilic inﬂammatory inﬁltrate in the dermis
(hematoxylineeosin 200); (B) perivascular neutrophil predominant dense inﬁltrate
and leucocytoclasia (hematoxylineeosin 400).
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upper and mid-dermis, as well as leukocytoclasis. No vasculitis was
observed (Figures 2A and 2B). Colchicine and dapsone, which
inhibit neutrophil chemotaxis, were used to treat the inﬁltrate.
However, because of the patient’s low hemoglobin level and the
occurrence of diarrhea, they were discontinued. The lesions were
attributed to poorly controlled RA, and the patient was referred to a
rheumatologist, who prescribedmethylprednisolone (10mg/d) and
methotrexate (10 mg/wk) for 2 months. The lesions gradually dis-
appeared. However, the patient stopped taking the methylpred-
nisolone and methotrexate because he was worried about the sideeffects. Two weeks after the treatment was stopped, the lesions
reappeared. At a 6-month follow-up visit, the patient complained
of severe arthralgia and widespread lesions involving his entire
body. He again refused systemic treatment with methylpredniso-
lone and methotrexate.Discussion
In 1989, Christensen et al1 reported two patients with chronically
recurring outbreaks of generalized annular erythematous, edema-
tous plaques. The histopathological ﬁndings were consistent with
Sweet syndrome; however, the patients presented without fever or
other ﬁndings characteristic of Sweet syndrome. Christensen et al1
regarded these two cases as a unique entity because of the annular
lesions and the absence of systemic manifestations, and used the
descriptive term “chronic recurrent annular neutrophilic derma-
tosis” for the condition, instead of considering it to be a variant of
Sweet syndrome.
Romero Aguilera et al2 reported four cases that manifested as
afebrile recurrent outbreaks occurring over a course of several
years. The clinical appearance and histopathological features of the
skin lesions of all four patients were suggestive of Sweet syndrome,
but none of the patients at any time developed leukocytosis or
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to be a variant of Sweet syndrome and not a separate entity.
Cabanillas et al3 reported a patient with a 6-month history of
generalized painful annular erythematous, edematous plaques. The
patient did not present with fever or leukocytosis, but did have
neutrophilia and an elevated erythrocyte sedimentation rate. The
lesions improved after a course of oral prednisone, and the patient
only had occasional mild recurrences. The authors considered their
case to resemble more closely Christensen et al’s1 CRAND instead of
being a variant of Sweet syndrome.
Koguchi et al4 described a case of ﬁgurate erythema that was
histopathologically characterized by neutrophilic inﬁltration. It was
successfully treated with potassium iodide. The authors thought
that their case could be considered to be a variant of CRAND.
In 2014, Mir-Bonafe et al5 reported a novel case of CRAND
associated with RA, as in our patient. They obtained a successful
outcome using dapsone plus colchine to prevent additional re-
currences over a 2-year follow-up period.
CRAND is a very rare condition; to the best of our knowledge,
only ﬁve cases have been reported to date. Since no association has
been found with drugs, infections, or systemic illness, its etiology
remains unknown.5 It is clinically characterized by recurrent out-
breaks of indurated annular plaques with erythematous borders
and a violaceous center. Fever, generalized symptoms such as
malaise and myalgia, leukocytosis, and neutrophilia are absent. The
histopathological ﬁndings include neutrophilic inﬁltration in the
mid and upper dermis, leukocytoclasia, and no signs of vasculitis.4,5
The one case of RA-associated CRAND reported by Mir-Bonafe
et al5 did not appear to manifest ﬂare ups of CRAND linked to ex-
acerbations of RA.We initially thought that the exacerbations of the
lesions of our patient were associated with poorly controlled RA,
and the rheumatologist who saw the patient prescribed systemic
methotrexate and methylprednisolone. The lesions disappeared 2
weeks after the start of treatment and reappeared after the cessa-
tion of treatment. We observed that the appearance of the lesions
was associated with worsening arthralgia.
RA skin manifestations can be either speciﬁc or nonspeciﬁc. The
speciﬁc manifestations include subcutaneous nodules (classical
rheumatoid nodules, accelerated rheumatoid nodules, or rheuma-
toid nodulosis), rheumatoid vasculitis, granulomatous dermatitides
(interstitial granulomatous dermatitis or palisaded neutrophilic
granulomatous dermatitis), and neutrophilic dermatosis (pyo-
derma gangrenosum, Sweet syndrome, rheumatoid neutrophilic
dermatitis, neutrophilic dermatitis of the dorsal hands, pyogenic
sterile arthritis, pyoderma gangrenosum, acne syndrome/synovitis,
acne, pustolosis, hyperostosis, osteomyelitis syndrome).6
RA-associated neutrophilic dermatosis has been linked to mu-
tations in the genes regulating innate immunity, which can induce
inﬂammasome-mediated neutrophil recruitment.7,8 Sweet syn-
drome is rarely seen in patients with RA, and is characterized his-
topathologically by a neutrophilic inﬁltrate in the superﬁcial dermaand clinically by the sudden onset of fever, an elevated white blood
cell count, and erythematous, tender skin lesions.9 Rheumatoid
neutrophilic dermatosis presents with papules, erythematous pla-
ques, nodules, and urticarial lesions with typical symmetric dis-
tributions on the joints, extensor surfaces of the extremities, and
the trunk. Histopathological ﬁndings include neutrophilic inﬁltrate
in the dermis without vasculitis.
The lesions of our patient most closely resembled those of pa-
tients with Sweet syndrome, except for the recurrent and annular
nature of the lesions and absence of constitutional signs and
symptoms such as fever and myalgia. We included rheumatoid
neutrophilic dermatosis in the differential diagnosis, but our pa-
tient’s lesions were edematous plaques instead of polymorphic
lesions or pustules, andwere distributedwidely instead of conﬁned
to the joints or extensor surfaces of the extremities.10
In conclusion, we described a rare case of a patient with RAwho
developed a neutrophilic dermatosis with an atypical, chronic, and
recurrent presentation. We think that “CRAND,” a descriptive term
ﬁrst used by Christensen et al,1 to be the most appropriate name for
this dermatological manifestation accompanied by clinical ﬁndings
different from those of classic Sweet syndrome. We suggest that
this is a new entity of RA-associated neutrophilic dermatosis, pre-
senting as recurring lesions that worsen with the exacerbation of
RA.
Additional studies of large series of similar cases can help us
clarify whether or not CRAND is a new type of RA-associated
neutrophilic dermatosis.References
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